Recently, Moffitt Ra et al. reported that pancreatic cancer was divided into basal-like and classical types based on tumor-specific gene expression, and the basal-like type was characterized by activated Kras and low GATA6 expression and was considered to have a poor prognosis [14]. The gene discussed is KRAS; the disease is pancreatic neoplasm.